Your browser doesn't support javascript.
loading
Evaluation of pharmacokinetic model designs for subcutaneous infusion of insulin aspart.
Mansell, Erin J; Schmidt, Signe; Docherty, Paul D; Nørgaard, Kirsten; Jørgensen, John B; Madsen, Henrik.
Afiliação
  • Mansell EJ; Centre for Bioengineering, University of Canterbury, Private Bag 4800, Christchurch, 8140, New Zealand.
  • Schmidt S; Department of Endocrinology, Hvidovre University Hospital, Kettegård Allé 30, 2650, Hvidovre, Denmark.
  • Docherty PD; Danish Diabetes Academy, Søndre Blvd. 29, 5000, Odense C, Denmark.
  • Nørgaard K; Centre for Bioengineering, University of Canterbury, Private Bag 4800, Christchurch, 8140, New Zealand. paul.docherty@canterbury.ac.nz.
  • Jørgensen JB; Department of Endocrinology, Hvidovre University Hospital, Kettegård Allé 30, 2650, Hvidovre, Denmark.
  • Madsen H; Department of Applied Mathematics and Computer Science, Technical University of Denmark, 2800, Kgs. Lyngby, Denmark.
J Pharmacokinet Pharmacodyn ; 44(5): 477-489, 2017 Oct.
Article em En | MEDLINE | ID: mdl-28831695
ABSTRACT
Effective mathematical modelling of continuous subcutaneous infusion pharmacokinetics should aid understanding and control in insulin therapy. Thorough analysis of candidate model performance is important for selecting the appropriate models. Eight candidate models for insulin pharmacokinetics included a range of modelled behaviours, parameters and complexity. The models were compared using clinical data from subjects with type 1 diabetes with continuous subcutaneous insulin infusion. Performance of the models was compared through several analyses R2 for goodness of fit; the Akaike Information Criterion; a bootstrap analysis for practical identifiability; a simulation exercise for predictability. The simplest model fit poorly to the data (R2 = 0.53), had the highest Akaike score, and worst prediction. Goodness of fit improved with increasing model complexity (R2 = 0.85-0.92) but Akaike scores were similar for these models. Complexity increased practical non-identifiability, where small changes in the dataset caused large variation (CV > 10%) in identified parameters in the most complex models. Best prediction was achieved in a relatively simple model. Some model complexity was necessary to achieve good data fit but further complexity introduced practical non-identifiability and worsened prediction capability. The best model used two linear subcutaneous compartments, an interstitial and plasma compartment, and two identified variables for interstitial clearance and subcutaneous transfer rate. This model had optimal performance trade-off with reasonable fit (R2 = 0.85) and parameterisation, and best prediction and practical identifiability (CV < 2%).
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Insulina Aspart / Modelos Cardiovasculares Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Pharmacokinet Pharmacodyn Assunto da revista: FARMACOLOGIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Nova Zelândia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Insulina Aspart / Modelos Cardiovasculares Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Pharmacokinet Pharmacodyn Assunto da revista: FARMACOLOGIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Nova Zelândia